AnaptysBio, Inc. (ANAB) Misses Q1 EPS by 5c

AnaptysBio, Inc. (NASDAQ: ANAB) reported Q1 EPS of ($1.64), $0.05 worse than the analyst estimate of ($1.59).

For earnings history and earnings-related data on AnaptysBio, Inc. (ANAB) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low